June 14, 2021
Glenmark and Teva want a Pennsylvania federal judge to reject the U.S. Department of Justice's proposed January 2022 trial date for criminal price-fixing charges against the generic drugmakers, arguing there's "no reason to rush" the complicated case.
June 08, 2021
Glenmark filed an unusual supplement Monday to a hearing over the U.S. Department of Justice's bid to disqualify Morgan Lewis & Bockius LLP from representing the drugmaker in a price-fixing case, saying a technical glitch prevented a recording of Glenmark's waiver of any conflict of interest.
May 05, 2021
A Pennsylvania federal judge said Wednesday he needed more information before deciding whether potential conflicts of interest barred Morgan Lewis & Bockius LLP from serving as counsel for drugmaker Glenmark in a criminal case over alleged price-fixing involving fellow Morgan Lewis client Teva Pharmaceuticals.